{"id":"doi:10.1016/j.neurol.2022.06.012","kind":"review","title":"High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects","authors":["Nicolas Villain","Vincent Planche","Richard Lévy"],"author_count":3,"year":2022,"published":"2022-09-29","venue":"Revue Neurologique","cited_by":87,"doi":"10.1016/j.neurol.2022.06.012","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1016/j.neurol.2022.06.012","archive_url":"https://space-kitty.com/papers/doi:10.1016/j.neurol.2022.06.012","updated":null,"pmid":"36184326","pmcid":null,"openalex_id":"W4298008358","pdf_url":"https://www.sciencedirect.com/science/article/pii/S003537872200738X/pdf","abstract":null,"abstract_license":null,"license":"cc-by-nc-nd","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Alzheimer's disease research and treatments"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"neurodegeneration","name":"Alzheimer's, Parkinson's & Neurodegeneration","domain_slug":"medicine"}],"cited_in_dossiers":[]}